Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) FCF Payout Ratio (2023 - 2024)

Historic FCF Payout Ratio for BioNexus Gene Lab (BGLC) over the last 2 years, with Q3 2024 value amounting to 0.0.

  • BioNexus Gene Lab's FCF Payout Ratio rose 4747.63% to 0.0 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.0, marking a year-over-year change of. This contributed to the annual value of 0.0 for FY2023, which is 12874.81% down from last year.
  • BioNexus Gene Lab's FCF Payout Ratio amounted to 0.0 in Q3 2024, which was up 4747.63% from 0.0 recorded in Q2 2024.
  • Over the past 5 years, BioNexus Gene Lab's FCF Payout Ratio peaked at 0.0 during Q3 2024, and registered a low of 0.05 during Q1 2024.